Guardian Pharmacy Services, Inc. Class A GRDN
NYSE · United States · Retail Trade
$40.78+0.10 (+0.25%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
ATLANTA, September 01, 2026--Guardian Pharmacy Services, Inc. (NYSE: GRDN) has acquired assets from Tennessee-based Nautilus Pharmacy.
ATLANTA, August 19, 2026--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will participate in the Jefferies Healthcare Services Conference, on Tuesday, September 15, 2026. Fred Burke, President and Chief Executive Officer, will participate in a fireside chat at 2:25 p.m. Central Standard Time that same day.
Why Guardian Pharmacy Services’ latest earnings matter for investors Guardian Pharmacy Services (GRDN) reported second quarter 2026 results on 6 August with higher net income versus a year earlier and updated full year guidance that points to higher expected revenue and adjusted EBITDA. Management linked the guidance change to underlying growth drivers, including mitigation of Inflation Reduction Act pricing pressures, recent acquisitions, new pharmacy openings, and a revised regional...
In the past week, Guardian Pharmacy Services, Inc. reported second-quarter 2026 results showing sales of US$351.77 million and net income of US$21.87 million, and it raised full-year 2026 revenue guidance to US$1.43 billion–US$1.45 billion while outlining ongoing expansion through acquisitions and new pharmacy openings. The combination of strong year-over-year profit growth, consistent earnings beats versus analyst estimates, and continued footprint expansion despite pricing pressure under...
Guardian Pharmacy Services, Inc. (NYSE:GRDN) reported second-quarter 2026 results and increased its financial guidance for the full year, sending shares up around 3.
Guardian Pharmacy Services Inc (GRDN) boosts full-year outlook on 23% adjusted EBITDA growth while navigating IRA pricing pressures and maintaining a robust M&A pipeline.
ATLANTA, August 06, 2026--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the second quarter ended June 30, 2026. The Company also raised its full-year guidance.
ATLANTA, July 15, 2026--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release second quarter 2026 financial results after market close on Thursday, August 6, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time.
ATLANTA, July 01, 2026--Guardian Pharmacy Services, Inc. (NYSE: GRDN) has acquired Wellness Concepts, a long-term care pharmacy based in Grottoes, Virginia.
ATLANTA, June 22, 2026--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that Kendall Forbes, who has served as Executive Vice President of Sales & Operations since 2004, has decided to retire, effective as of July 1, 2026. Upon Mr. Forbes’s retirement, David Morris, currently Executive Vice President and Chief Financial Officer of Guardian will assume the role of Chief Operating Officer. In connection with Mr. Morris’ new role, Will Mudd, Senior Vice President, Finance, has been ap
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.